Skip to main content
Livermore
Livermore
ZHEN

Propel Bio Management, LLC

SEC CIK
0001969764
Latest filing
Aug 13, 2026

Holdings in Q2 2026

Holdings as of Jun 30, 2026, filed Aug 13, 2026. Long positions only; changes compare share counts with Q1 2026.

Institution overview
Positions
29
−9 vs. Q1 2026
Portfolio value
$191.1M
+$32.4M (+20.4%) vs. Q1 2026
Filed
Aug 13, 2026
SEC
Holdings of Propel Bio Management, LLC in Q2 2026
SecurityClassSharesValue% of portfolioShare changeActionHistory
PAGPPlains GP Holdings LPLTD PARTNR INT A1,272,360$30.9M16.2%00.0%UnchangedHistory
ACHVAchieve Life Sciences, Inc.COM4,034,018$26.3M13.8%+247,593+6.5%AddedHistory
CORTCorcept Therapeutics IncCOM136,499$11.9M6.2%−11,329−7.7%ReducedHistory
PHATPhathom Pharmaceuticals, Inc.COM1,050,358$11.4M6.0%+209,086+24.9%AddedHistory
DCTHDelcath Systems, Inc.COM NEW871,460$11.0M5.7%−108,238−11.0%ReducedHistory
MISTMilestone Pharmaceuticals Inc.COM7,429,590$9.96M5.2%+3,311,269+80.4%AddedHistory
CMPSCOMPASS Pathways plcSPONSORED ADS573,086$8.11M4.2%−168,963−22.8%ReducedHistory
KYTXKyverna Therapeutics, Inc.COM883,198$7.87M4.1%+238,777+37.1%AddedHistory
ARTVArtiva Biotherapeutics, Inc.COM696,436$6.76M3.5%+550,067+375.8%AddedHistory
ABEOAbeona Therapeutics Inc.COM NEW983,070$6.08M3.2%−346,829−26.1%ReducedHistory
AQSTAquestive Therapeutics, Inc.COM1,442,397$6.00M3.1%+731,409+102.9%AddedHistory
PALIPalisade Bio, Inc.COM2,582,388$5.40M2.8%+1,467,388+131.6%AddedHistory
IMUXImmunic, Inc.COM NEW325,022$5.00M2.6%+90,544+38.6%AddedConverted for a 1-for-10 splitHistory
IVAInventiva S.A.ADS1,281,212$4.84M2.5%+556,534+76.8%AddedHistory
SABSSAB Biotherapeutics, Inc.COM NEW1,076,578$4.20M2.2%+63,788+6.3%AddedHistory
OBIOOrchestra BioMed Holdings, Inc.COM896,701$3.87M2.0%00.0%UnchangedHistory
CLDXCelldex Therapeutics, Inc.COM NEW103,695$3.86M2.0%−27,669−21.1%ReducedHistory
ZVRAZevra Therapeutics, Inc.COM NEW253,544$3.64M1.9%−28,874−10.2%ReducedHistory
OCULOcular Therapeutix, IncCOM357,966$3.52M1.8%−24,409−6.4%ReducedHistory
FDMT4D Molecular Therapeutics, Inc.COM252,654$3.36M1.8%−127,766−33.6%ReducedHistory
OVIDOvid Therapeutics Inc.COM1,115,538$3.00M1.6%+194,081+21.1%AddedHistory
EYPTEyePoint, Inc.COM NEW191,745$2.74M1.4%−24,080−11.2%ReducedHistory
UPBUpstream Bio, Inc.COM350,389$2.42M1.3%+8,610+2.5%AddedHistory
SCYXScynexis IncCOM543,478$2.21M1.2%+543,478NewHistory
SLNSilence Therapeutics plcADS191,733$2.11M1.1%+191,733NewHistory
LONALeonaBio, Inc.COM149,279$1.37M0.7%00.0%UnchangedHistory
MAZEMaze Therapeutics, Inc.COM43,798$1.31M0.7%00.0%UnchangedHistory
CRVSCorvus Pharmaceuticals, Inc.COM70,380$1.05M0.6%−15,411−18.0%ReducedHistory
SGMTSagimet Biosciences Inc.COM SER A125,878$973.0K0.5%+125,878NewHistory

Sold out since Q1 2026 (12)

Positions held at the end of Q1 2026 that are gone from this filing.

Positions of Propel Bio Management, LLC sold out since Q1 2026
SecurityClassShares in Q1 2026Value in Q1 2026% of portfolio in Q1 2026History
VORVor Biopharma Inc.COM NEW314,543$5.59M3.5%History
VRDNViridian Therapeutics, Inc.COM210,163$4.09M2.6%History
OCSOculis Holding AGORDINARY SHARES122,223$3.28M2.1%History
TRVITrevi Therapeutics, Inc.COM223,802$2.65M1.7%History
CHRSCoherus Oncology, Inc.COM1,420,550$2.41M1.5%History
KLRSKalaris Therapeutics, Inc.COM295,771$1.72M1.1%History
QUREuniQure N.V.SHS104,772$1.71M1.1%History
NUVBNuvation Bio Inc.COM CL A329,296$1.41M0.9%History
EVMNEvommune, Inc.COM SHS55,664$1.28M0.8%History
ALDXAldeyra Therapeutics, Inc.COM730,606$1.23M0.8%History
CNTBConnect Biopharma Holdings LtdSHS209,493$553.9K0.3%History
MSLESatellos Bioscience Inc.COM10,145$57.1K<0.1%History